Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Journal of Research in Pharmacy Practice
|
June 4, 2020
Glycemic Control after Initiating Direct-Acting Antiviral Agents in Patients with Hepatitis C Virus and Type 2 Diabetes Mellitus Using the United States Integrated Healthcare System
Alicia Halim Wong, John Sie, Angela Chen, et al.
Pancreas
|
August 13, 2016
All-Cause and Acute Pancreatitis Health Care Costs in Patients With Severe Hypertriglyceridemia
Nazia Rashid, Puza P Sharma, Ronald D Scott, et al.
Cancer Reports (Hoboken, N.J.)
|
May 19, 2025
Meta-Analysis of Recurrence-Free Survival or Disease-Free Survival as a Potential Surrogate Endpoint for Overall Survival in Esophageal Cancer Trials
Uchechukwu Love Anyaduba, Oluwatosin Qawiyy Orababa, Zion Faye, et al.
Neurology and Therapy
|
May 11, 2025
The Modified Functional Status Questionnaire for Assessing Patients with Parkinson's Disease Psychosis Treated with Pimavanserin: A Post Hoc Analysis
Virgilio G H Evidente, Lambros Chrones, Ratna Revankar, et al.
Neurology and Therapy
|
June 1, 2026
Utilization of Non-pharmacological Interventions in Rett Syndrome: A Systematic Review of the Literature on Supportive Care Management
Nazia Rashid, Safiuddin Shoeb Syed, Krithika Rajagopalan, et al.
Journal of Clinical Lipidology
|
September 1, 2016
Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system
Nazia Rashid, Puza P Sharma, Ronald D Scott, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 26, 2013
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain
Carole Dembek, Leigh Ann White, Jayson Quach, et al.
Journal of Comparative Effectiveness Research
|
October 27, 2025
Real-world evidence of pimavanserin utilization among patients with Parkinson's disease psychosis: a review of real-world data that augments data from randomized controlled trials
Nazia Rashid, Ismaeel Yunusa, Dilesh Doshi, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
A Descriptive Evaluation of Prescriber Perceptions and Experience With Risk Evaluation and Mitigation Strategy (REMS) Programs in an Integrated Health Care System
Nazia Rashid, T Craig Cheetham, Gustavus Aranda, et al.
Advances in Therapy
|
March 5, 2022
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
Ismaeel Yunusa, Nazia Rashid, George N Demos, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Journal of Research in Pharmacy Practice
|
June 4, 2020
Glycemic Control after Initiating Direct-Acting Antiviral Agents in Patients with Hepatitis C Virus and Type 2 Diabetes Mellitus Using the United States Integrated Healthcare System
Alicia Halim Wong, John Sie, Angela Chen, et al.
Pancreas
|
August 13, 2016
All-Cause and Acute Pancreatitis Health Care Costs in Patients With Severe Hypertriglyceridemia
Nazia Rashid, Puza P Sharma, Ronald D Scott, et al.
Cancer Reports (Hoboken, N.J.)
|
May 19, 2025
Meta-Analysis of Recurrence-Free Survival or Disease-Free Survival as a Potential Surrogate Endpoint for Overall Survival in Esophageal Cancer Trials
Uchechukwu Love Anyaduba, Oluwatosin Qawiyy Orababa, Zion Faye, et al.
Neurology and Therapy
|
May 11, 2025
The Modified Functional Status Questionnaire for Assessing Patients with Parkinson's Disease Psychosis Treated with Pimavanserin: A Post Hoc Analysis
Virgilio G H Evidente, Lambros Chrones, Ratna Revankar, et al.
Neurology and Therapy
|
June 1, 2026
Utilization of Non-pharmacological Interventions in Rett Syndrome: A Systematic Review of the Literature on Supportive Care Management
Nazia Rashid, Safiuddin Shoeb Syed, Krithika Rajagopalan, et al.
Journal of Clinical Lipidology
|
September 1, 2016
Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system
Nazia Rashid, Puza P Sharma, Ronald D Scott, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 26, 2013
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain
Carole Dembek, Leigh Ann White, Jayson Quach, et al.
Journal of Comparative Effectiveness Research
|
October 27, 2025
Real-world evidence of pimavanserin utilization among patients with Parkinson's disease psychosis: a review of real-world data that augments data from randomized controlled trials
Nazia Rashid, Ismaeel Yunusa, Dilesh Doshi, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
A Descriptive Evaluation of Prescriber Perceptions and Experience With Risk Evaluation and Mitigation Strategy (REMS) Programs in an Integrated Health Care System
Nazia Rashid, T Craig Cheetham, Gustavus Aranda, et al.
Advances in Therapy
|
March 5, 2022
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
Ismaeel Yunusa, Nazia Rashid, George N Demos, et al.
Page
of 7